Intravenous Iron May Increase Depression Among Hemodialysis Patients
1 other identifier
observational
112
0 countries
N/A
Brief Summary
the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2017
CompletedFirst Submitted
Initial submission to the registry
May 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2017
CompletedFirst Posted
Study publicly available on registry
May 17, 2017
CompletedMay 17, 2017
May 1, 2017
1.3 years
May 16, 2017
May 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change in patient health questionnaire-9 score
change in patient health questionnaire-9 score before and after intravenous iron therapy
on day 0 of start of intravenous iron and 1 week after completion of intravenous iron
Interventions
each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses
Eligibility Criteria
Hemodialysis patients with iron deficiency anemia.
You may qualify if:
- age was above 19 years,
- patient on maintenance hemodialysis,
- patient had iron deficiency anemia (ferritin \> 100 ng/ml)
You may not qualify if:
- patient has history of depression or already using antidepressant medication,
- Lack of ferritin level increase ≥ 50% from baseline level before IV iron administration,
- patient already on oral or intravenous iron supplement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Benha Universitylead
- New Jeddah Clinic Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud Hamada, MD
Benha University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Internal Medicine - Faculty of Medicine
Study Record Dates
First Submitted
May 16, 2017
First Posted
May 17, 2017
Study Start
January 14, 2016
Primary Completion
May 15, 2017
Study Completion
May 16, 2017
Last Updated
May 17, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share